Bayer A J, Pathy M S, Ankier S I
Pharmatherapeutica. 1983;3(7):468-74.
A double-blind, parallel group, randomized trial was carried out to compare the hypnotic efficacy of 1.0 mg loprazolam and 5.0 mg nitrazepam in 40 elderly patients. All had disturbed sleep patterns, which were not the result of physical illness, and had been shown to be placebo non-responders during a 3-day placebo screening period. Patients received active medication for 7 nights. Both loprazolam and nitrazepam significantly improved sleep patterns, as measured by patient self-rating scales and night nurses' global assessments, in comparison with the placebo baseline screen (p less than 0.001). No significant differences in efficacy were shown between drug treatments and no untoward effects were recorded which could be attributed to either drug. The results suggest that 1.0 mg loprazolam is an effective and well-tolerated hypnotic in elderly patients suffering from insomnia.
一项双盲、平行组、随机试验在40名老年患者中开展,以比较1.0毫克氯普唑仑和5.0毫克硝西泮的催眠效果。所有患者均有睡眠模式紊乱,且并非由身体疾病所致,并且在为期3天的安慰剂筛查期内已被证明对安慰剂无反应。患者接受了7晚的活性药物治疗。与安慰剂基线筛查相比,通过患者自评量表和夜班护士的整体评估衡量,氯普唑仑和硝西泮均显著改善了睡眠模式(p小于0.001)。两种药物治疗之间未显示出疗效上的显著差异,也未记录到可归因于任何一种药物的不良影响。结果表明,1.0毫克氯普唑仑对患有失眠症的老年患者是一种有效且耐受性良好的催眠药。